Sjögren's syndrome is a chronic autoimmune condition primarily causing dry eyes and mouth, often requiring a multifaceted approach to manage symptoms and associated health concerns.

Sjögren's syndrome (SS) is a systemic autoimmune disorder characterized by the immune system mistakenly attacking the body's own exocrine glands, particularly those responsible for producing tears and saliva [1, 2, 3]. This attack leads to inflammation and lymphocytic infiltration of these glands, resulting in the hallmark symptoms of dry eyes and dry mouth [1, 2, 3].

There are two main types of Sjögren's syndrome. Primary Sjögren's syndrome (pSS) occurs on its own, while secondary Sjögren's syndrome develops in individuals who already have other rheumatic disorders, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), or scleroderma [1].

Recognizing Symptoms and Diagnosis

The most common and characteristic symptoms of Sjögren's syndrome are persistent dry eyes (xerophthalmia or keratoconjunctivitis sicca) and dry mouth (xerostomia) [1, 3, 4, 5]. Dry eyes can manifest as a gritty or burning sensation, while dry mouth can make speaking, chewing, and swallowing difficult [3].

Beyond the primary glandular symptoms, Sjögren's syndrome is a systemic condition, meaning it can affect other parts of the body. While it commonly impacts the upper gastrointestinal tract, rare cases of small intestine involvement have been reported [3]. Other potential systemic manifestations can include joint pain, skin rashes, lung issues, blood abnormalities, kidney problems, and neurological involvement [7].

Diagnosis of Sjögren's syndrome typically involves a combination of clinical symptoms and specific tests. These may include blood tests to check for certain antibodies, such as antinuclear antibodies (ANA), rheumatoid factor (RF), and Sjögren's syndrome A (SSA) antibodies. A biopsy of the salivary lip gland can also provide diagnostic evidence of the characteristic lymphocytic infiltration [3].

Addressing Dry Eyes

Dry eyes are a significant challenge for individuals with Sjögren's syndrome, often referred to as keratoconjunctivitis sicca or xerophthalmia [4]. The lymphocytic infiltration of the lacrimal (tear-producing) glands reduces tear production, leading to discomfort and potential damage to the ocular surface [1].

Management strategies for dry eyes in Sjögren's syndrome primarily focus on alleviating dryness and protecting the eye surface. While specific treatments were not detailed in the provided sources, the goal is to enhance lubrication and reduce symptoms, often through various supportive care measures tailored to the individual's needs.

Managing Dry Mouth

Xerostomia, or dry mouth, is another central symptom of Sjögren's syndrome, resulting from the immune system's attack on the salivary glands [1, 2, 3]. Sjögren's syndrome is considered the most common disease causing xerostomia [5]. This persistent dryness can lead to difficulties with eating, speaking, and swallowing, and can increase the risk of dental problems [3].

Similar to dry eyes, the management of dry mouth in Sjögren's syndrome aims to relieve symptoms and maintain oral health. While specific interventions were not detailed in the provided sources, approaches typically focus on stimulating saliva production, using saliva substitutes, and practicing diligent oral hygiene to mitigate the effects of reduced saliva.

The Link to Thyroid Health

Individuals with Sjögren's syndrome have a significantly increased risk of developing thyroid disease compared to the general population. A meta-analysis found that the risk of thyroid disease in patients with SS was more than three times higher (Odds Ratio, 3.29; 95% CI [2.08-5.21]) [2].

Studies have shown a high prevalence of various thyroid conditions, including Hashimoto's thyroiditis, subacute thyroiditis, subclinical hypothyroidism, and Graves' disease, among individuals experiencing xerostomia, including those diagnosed with Sjögren's syndrome [5]. This connection highlights the systemic nature of autoimmune conditions and the importance of monitoring thyroid function in SS patients.

Furthermore, thyroid disease itself can contribute to ocular issues. Dry eye disease (DED) is prevalent in patients with papillary thyroid carcinoma, with findings indicating lower thyroid-stimulating hormone (TSH) values and a higher proportion of meibomian gland atrophy in affected individuals [8]. In some cases, thyroid dysfunction can lead to Thyroid Eye Disease (TED), which involves upper eyelid abnormalities such as retraction and swelling, requiring specific management strategies ranging from supportive care to systemic medications and surgery [6]. While TED is distinct from Sjögren's-related dry eyes, the increased risk of thyroid disease in SS patients means clinicians may need to consider these related ocular complications.

Systemic Treatment Approaches

For systemic manifestations of Sjögren's syndrome beyond dry eyes and mouth, various treatments may be considered. Glucocorticoids (GCs), known for their anti-inflammatory and immunosuppressive properties, are commonly used in Sjögren's syndrome for glandular, joint, skin, lung, blood, kidney, and neurological involvement [7].

However, it is important to note that compared to other autoimmune rheumatic diseases like rheumatoid arthritis and systemic lupus erythematosus, reliable evidence for the widespread use of systemic glucocorticoids in Sjögren's syndrome is more limited, often based on case reports, case studies, and smaller observational studies rather than large randomized controlled trials [7]. Treatment decisions for Sjögren's syndrome are highly individualized and made in consultation with a healthcare provider, considering the specific symptoms and systemic involvement.

Sources

This article summarises published research for a general audience. It is not medical advice — talk to a qualified clinician about your own situation. Need help finding one? Browse doctors.